Skip to main content

Table 1 Clinical characteristics of study subjects

From: Prospective randomized study for optimal insulin therapy in type 2 diabetic patients with secondary failure

 

Total

30 mix

Basal Bolus

p

n

42

21

21

 

Male(%)

31 (73.8)

16 (76.2)

15 (71.4)

0.73

Age (y)

64.5 (56.8–71.0)

63.0 (55.5–71.0)

65.0 (59.0–70.5)

0.65

BMI(kg/m2)

23.7 (21.9–26.1)

23.8 (21.7–26.3)

23.5 (22.4–26.3)

0.79

HbA1c(%)

9.2 (7.9–10.6)

9.3 (8.1–11.3)

8.9 (7.7–10.0)

0.24

Duration of SU drug use (y)

11.0 (6.0–15.3)

11.0 (5.0–16.5)

10.0 (6.5–15.0)

0.76

  1. Data are expressed as frequencies (%), or median (inter quartile range). The sex ratio between the groups were compared using chi-square test. The medians of other data were compared using Wilcoxon rank-sum test. BMI: Body Mass Index. SU: sulfonylurea.